Cytosorbents
CTSO
#10587
Rank
โ‚น2.38 B
Marketcap
โ‚น37.97
Share price
3.61%
Change (1 day)
-51.74%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚น1.13 Billion

According to Cytosorbents's latest financial reports the company's current earnings are โ‚น37.2 Million. In 2025 the company made an earning of -โ‚น0.82 Billion, an increase over its 2024 earnings that were of -โ‚น2.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.13 Billion37.11%
2025 -โ‚น0.82 Billion-62.16%
2024 -โ‚น2.17 Billion-22.49%
2023 -โ‚น2.8 Billion-13.52%
2022 -โ‚น3.23 Billion34.04%
2021 -โ‚น2.41 Billion182.17%
2020 -โ‚น0.86 Billion-55.97%
2019 -โ‚น1.94 Billion14.17%
2018 -โ‚น1.7 Billion95.14%
2017 -โ‚น0.88 Billion-22.32%
2016 -โ‚น1.13 Billion39.1%
2015 -โ‚น0.81 Billion-12.89%
2014 -โ‚น0.93 Billion89%
2013 -โ‚น0.49 Billion26.65%
2012 -โ‚น0.39 Billion-26.02%
2011 -โ‚น0.53 Billion-288.45%
2010 โ‚น0.27 B-4.17%
2009 โ‚น0.28 B-287.19%
2008 -โ‚น0.16 Billion-47.12%
2007 -โ‚น0.3 Billion41.78%
2006 -โ‚น0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚น356.48 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚น74.07 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚น5.28 B-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA